CV Sciences

(OTC: CVSI)
Healthcare  |  Drug Manufacturers—Specialty & Generic
0.46 0.0335 7.79%
Stock Price | Nov. 27, 2020, 12:59 p.m.
12 Followers
Bid: 0.4635
Ask: 0.468
Prev. Close: 0.43
52 Week Low: 0.35
52 Week High: 1.27
PE Ratio: 0.0
Dividend Yield: 0.0%

Company Summary

CV Sciences Inc is a pharmaceutical company. The group operates in two segments consumer products and specialty pharmaceutical. The consumer products segment develops, manufactures and markets products based on hemp-based Cannabidiol (CBD). Whereas the specialty pharmaceutical segment is developing drug candidates which use CBD as a primary active ingredient.

Read more Read less

Recently Viewed Tickers

Premium Cannabis Stocks Review - Pre-Market Edition 11/27/20

7 Comments
3 days ago

Premium Weekly Review 11/06/20

3 weeks ago

Premium Weekly Review 10/09/20

1 month ago

Premium Cannabis Stocks Review - Pre-Market Edition 09/15/20

4 Comments
2 months ago

Premium Weekly Review 09/11/20

2 months ago

Premium Cannabis Stocks Review - Pre-Market Edition 09/11/20

6 Comments
2 months ago

Premium Cannabis Stocks Review - AM Edition 09/08/20

4 Comments
2 months ago

Premium Weekly Review 09/04/20

2 months ago

Premium Cannabis Stocks Review - Pre-Market Edition 09/03/20

4 Comments
2 months ago